The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cells

Lysophophatidylcholine (LysoPC) is an abundant constituent in human plasma. Patients with malignant cancer diseases have attenuated LysoPC plasma levels, and thus LysoPC has been examined as a metabolic biomarker for cancer prediction. Preclinical studies have shown that solid tumor cells drasticall...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Thomas, Jakubzig, Bastian, Grundmann, Manuel, Massing, Ulrich, Kostenis, Evi, Schlesinger, Martin, Bendas, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324772/
https://www.ncbi.nlm.nih.gov/pubmed/28255537
http://dx.doi.org/10.1002/2211-5463.12152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324772/
https://www.ncbi.nlm.nih.gov/pubmed/28255537
http://dx.doi.org/10.1002/2211-5463.12152

Ejemplares similares